FrancophonIA/ELRC3.0 huggingface dataset:
English: Ciprofloxacin and amoxicillin plus clavulanic acid Reductions in pre-dose (trough) MPA concentrations of about 50 % have been reported in renal transplant recipients in the days immediately following commencement of oral ciprofloxacin or amoxicillin plus clavulanic acid.
Slovenian: Ciprofloksacin in amoksicilin s klavulansko kislino Pri bolnikih z ledvičnim presadkom so v dneh, ki so sledili začetku zdravljenja s peroralnim ciprofloksacinom ali amoksicilinom s klavulansko kislino, poročali o zmanjšanju najnižje koncentracije mikofenolne kisline pred naslednjim odmerkom za približno 50 %.
English: Marketing Authorisation Holder Passauer Pharma GmbH Eiderstedter Weg 3
Slovenian: Imetnik dovoljenja za promet z zdravilom Passauer Pharma GmbH Eiderstedter Weg 3
English: Following oral administration, mycophenolate mofetil undergoes rapid and extensive absorption and complete presystemic metabolism to the active metabolite, MPA.
Slovenian: Mofetilmikofenolat se po peroralni uporabi hitro in dobro absorbira ter v celoti predsistemsko presnovi v aktivni presnovek mikofenolno kislino.
English: Myclausen 250 mg capsules is available PVC-aluminium blister containing 10 capsules.
Slovenian: 250 mg so pakirane v PVC-aluminijastih pretisnih omotih, ki vsebujejo 10 kapsul.
English: No pharmacokinetic data are available during hepatic transplant rejection.
Slovenian: Podatki o farmakokinetiki pri zavrnitvi jetrnega presadka niso znani.
English: No data are available for paediatric cardiac transplant patients.
Slovenian: Pediatrični bolniki Za otroke s srčnim presadkom podatkov ni.
English: • A kidney, heart or liver.
Slovenian: • Presadek je lahko ledvični, srčni ali jetrni.
English: Female patients of reproductive potential must be made aware of the increased risk of pregnancy loss and congenital malformations at the beginning of the treatment and must be counselled regarding pregnancy prevention and planning.
Slovenian: Bolnice v rodni dobi se morajo zavedati, da obstaja večje tveganje za izgubo nosečnosti in kongenitalne malformacije na začetku zdravljenja.
English: Delayed renal graft function
Slovenian: Zapoznelo delovanje ledvičnega presadka
English: When comparing rates of transplant rejection or rates of graft loss between mycophenolate mofetil patients taking PPIs versus mycophenolate mofetil patients not taking PPIs, no significant differences were seen.
Slovenian: Pri primerjavi deležev zavrnitve presadka ali deležev izgube presadka med bolniki, ki so jemali zdravilo mofetilmikofenolata in zaviralce protonske črpalke ter bolniki, ki so jemali zdravilo mofetilmikofenolata in niso jemali zaviralcev protonske črpalke, niso opazili značilnih razlik.
English: Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil. Renal transplant rejection does not lead to changes in MPA pharmacokinetics; dosage reduction or interruption of Myclausen is not required.
Slovenian: Zavrnitev ledvičnega presadka ne spremeni farmakokinetike mikofenolne kisline; zmanjšanje odmerkov ali prekinitev zdravljenja z zdravilom Myclausen ni potrebna.
English: The full name of your medicine is Myclausen 250 mg hard capsules.
Slovenian: Celotno ime zdravila je Myclausen 250 mg kapsule.
English: Patients receiving immunosuppressive regimens involving combinations of medicinal products, including Myclausen, are at increased risk of developing lymphomas and other malignancies, particularly of the skin (see section 4.8).
Slovenian: Bolniki, ki prejemajo kombinacije imunosupresivnih zdravil, vključno z zdravilom Myclausen, so izpostavljeni povečanemu tveganju nastanka limfomov in drugih malignih sprememb, zlasti kožnih (glejte poglavje 4.8).
English: • Myclausen treatment should not be initiated in women of child bearing potential without providing a pregnancy test result to rule out unintended use in pregnancy (see section 4.6).
Slovenian: Zdravljenja z zdravilom Myclausen ne smemo uvesti pri bolnicah v rodni dobi, ki ne zagotovijo izvida testa nosečnosti, da izključimo nenamerno uporabo zdravila med nosečnostjo (glejte poglavje 4.6).
English: PVC-aluminium blisters containing 10 hard capsules.
Slovenian: PVC-aluminijasti pretisni omot vsebuje 10 trdih kapsul.
English: Spontaneous abortion (rate of 45% to 49%) and congenital malformations (estimated rate of 23% to 27%) have been reported following MMF exposure during pregnancy.
Slovenian: Po izpostavljenosti mofetilmikofenolatu med nosečnostjo so poročali o spontanem splavu (ocenjeni delež 45-49 %) in kongenitalnih malformacijah (ocenjeni delež 23-27 %).
English: In particular, tell your doctor or pharmacist if you are taking any of the following medicines before you start Myclausen:
Slovenian: Pred začetkom zdravljenja z zdravilom Myclausen, povejte zdravniku ali farmacevtu zlasti, ali jemljete katerokoli izmed naslednjih zdravil:
English: Elderly patients may be at an increased risk of adverse events such as certain infections (including cytomegalovirus tissue invasive disease) and possibly gastrointestinal haemorrhage and pulmonary oedema, compared with younger individuals (see section 4.8).
Slovenian: Pri starejših bolnikih je v primerjavi z mlajšimi posamezniki možno povečano tveganje za neželene učinke, kot so določene okužbe (vključno z invazivno okužbo tkiva s citomegalovirusom) in krvavitve iz prebavil ter pljučni edem (glejte poglavje 4.8).
English: Cases of pure red cell aplasia (PRCA) have been reported in patients treated with mycophenolate mofetil (see section 4.4).
Slovenian: Pri zdravljenju z mofetilmikofenolatom so poročali o primerih čiste aplazije rdečih krvnih celic (PRCA) (glejte poglavje 4.4).
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Slovenian: Obvestite zdravnika ali farmacevta, ali jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, vključno z zdravili, ki ste jih dobili brez recepta ali zdravili rastlinskega izvora, ker lahko zdravilo Myclausen vpliva na delovanje nekaterih drugih zdravil.
English: • Myclausen should not be given to women who are breastfeeding (see section 4.6).
Slovenian: Zdravila Myclausen ne smemo uporabljati pri bolnicah, ki dojijo (glejte poglavje 4.6).
English: Co-administration of probenecid with mycophenolate mofetil in monkeys raises plasma AUC of MPAG by 3-fold.
Slovenian: Sočasno jemanje probenecida in mofetilmikofenolata je pri opicah povzročilo zvišanje AUC mikofenolglukuronida v plazmi za trikrat.
English: These infections are often related to a high total immunosuppressive burden and may lead to serious or fatal conditions that physicians should consider in the differential diagnosis in immunosuppressed patients with deteriorating renal function or neurological symptoms.
Slovenian: Te okužbe so pogosto povezane z visokim imunosupresivnim bremenom in lahko vodijo v resna ali smrtna stanja.
English: However, in renal transplant patients, tacrolimus concentration did not appear to be altered by mycophenolate mofetil (see also section 4.4).
Slovenian: Pri bolnikih z ledvičnim presadkom pa mofetilmikofenolat ni spremenil koncentracije takrolimusa (glejte tudi poglavje 4.4).
English: Do not take Myclausen if you are breast-feeding.
Slovenian: Ne jemljite zdravila Myclausen, če dojite.
English: A reduction in the AUC of MPA of approximately 40 % is associated with the co-administration of cholestyramine (4 g TID), indicating that there is a significant amount of enterohepatic recirculation.
Slovenian: Holestiramin v odmerku 4 g 3-krat na dan zmanjša AUC mikofenolne kisline za približno 40 %, kar potrjuje veliko stopnjo ponovnega enterohepatičnega obtoka.
English: At clinically encountered concentrations, MPA and MPAG are not removed by haemodialysis.
Slovenian: Pri kliničnih koncentracijah mikofenolne kisline in mikofenolglukuronida ne odstranimo s hemodializo.
English: In contrast, if concomitant ciclosporin treatment is stopped, an increase in MPA AUC of around 30 % should be expected.
Slovenian: Mofetilmikofenolat ne vpliva na farmakokinetiko ciklosporina A. Če pa sočasno zdravljenje s ciklosporinom prekinemo, lahko pričakujemo povečanje AUC mikofenolne kisline za približno 30 %.
English: Myclausen contains mycophenolate mofetil.
Slovenian: Zdravilo Myclausen vsebuje mofetilmikofenolat.
English: Two complementary forms of contraception simultaneously are preferred to minimise the potential for contraceptive failure and unintended pregnancy.
Slovenian: Za zmanjšanje možnega nedelovanja kontraceptiva in nenamerne nosečnosti na najmanjšo možno mero je priporočljivo hkrati uporabljati dve zanesljivi obliki kontracepcije.
English: Patients receiving immunosuppressive regimens involving combinations of medicinal products, including mycophenolate mofetil, are at increased risk of developing lymphomas and other malignancies, particularly of the skin (see section 4.4).
Slovenian: Bolniki, ki prejemajo imunosupresivna zdravila, obsegajoč kombinacije zdravil, vključno z mofetilmikofenolatom, imajo zvečano tveganje nastanka limfomov in drugih malignih sprememb, zlasti kožnih (glejte poglavje 4.4).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/10/647/003 (100 hard capsules)
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/10/647/003 (100 trdih kapsul)
English: The following undesirable effects cover adverse reactions from post-marketing experience The types of adverse reactions reported during post-marketing with mycophenolate mofetil are similar to those seen in the controlled renal, cardiac and hepatic transplant studies.
Slovenian: Neželeni učinki, ki so se pojavili med trženjem mofetilmikofenolata, so podobni neželenim učinkom v nadzorovanih raziskavah bolnikov z ledvičnim, srčnim in jetrnim presadkom.
English: Furthermore, men should not donate semen during therapy or for 90 days following discontinuation of mycophenolate.
Slovenian: Bolniki prav tako ne smejo darovati semena med zdravljenjem in 90 dni po zaključku zdravljenja z mofetilmikofenolatom.
English: NAME OF THE MEDICINAL PRODUCT Myclausen 250 mg hard capsules
Slovenian: IME ZDRAVILA Myclausen 250 mg trde kapsule
English: Myclausen capsules should only be prescribed to patients with a body surface area of at least 1.25 m 2.
Slovenian: Kapsule Myclausen lahko predpišemo samo bolnikom, katerih telesna površina je večja od 1,25 m2. Pacientom, katerih telesna površina je od 1,25 do 1,5 m lahko predpišemo kapsule
English: The recommended dose of 1 g administered twice a day for renal transplant patients and 1.5 g twice a day for cardiac or hepatic transplant patients is appropriate for the elderly.
Slovenian: Priporočeni odmerek za starejše bolnike je 1 g dvakrat na dan za bolnike z ledvičnim presadkom in 1,5 g dvakrat na dan za starejše bolnike s srčnim ali jetrnim presadkom.
English: Lung problems such as:
Slovenian: Težave z dihali, kot so:
English: Intravenous mycophenolate mofetil should be administered for the first 4 days following hepatic transplant, with oral Myclausen initiated as soon after this as it can be tolerated.
Slovenian: Prve 4 dni po presaditvi jeter je treba dajati mofetilmikofenolat intravensko, takoj ko je bolnik sposoben požirati, pa nadaljujemo s peroralno obliko zdravila Myclausen.
English: • swelling of the gums and mouth ulcers
Slovenian: • otekanje dlesni in razjede v ustih,
English: NAME OF THE MEDICINAL PRODUCT Myclausen 500 mg film-coated tablets
Slovenian: IME ZDRAVILA Myclausen 500 mg filmsko obložene tablete
English: Digestive system and mouth problems such as:
Slovenian: Težave s prebavili in usti, kot so:
English: Following single dose administration of 1.5 g of mycophenolate mofetil to normal healthy subjects pre-treated with 4 g TID of cholestyramine for 4 days, there was a 40 % reduction in the AUC of MPA (see section 4.4 and section 5.2).
Slovenian: Če dajemo holestiramin 4 dni v odmerku 4 g trikrat na dan, ta zmanjša AUC mikofenolne kisline po enkratnem peroralnem vnosu 1,5 g mofetilmikofenolata za približno 40 % (glejte poglavje 4.4 in poglavje 5.2).
English: Myclausen 500 mg film-coated tablets Mycophenolate mofetil
Slovenian: Myclausen 500 mg filmsko obložene tablete mofetilmikofenolat
English: Microcrystalline cellulose Povidone (K-30) Croscarmellose sodium Magnesium stearate
Slovenian: Jedro tablet mikrokristalna celuloza povidon (K-30) premrežen natrijev karmelozat magnezijev stearat
English: The systemic exposure at these levels is approximately equivalent to or less than 0.5 times the clinical exposure at the recommended clinical dose of 2 g/day for renal transplant patients and approximately 0.3 times the clinical exposure at the recommended clinical dose of 3 g/day for cardiac transplant patients (see section 4.6).
Slovenian: Sistemska izpostavljenost pri tem odmerku je bila približno enaka ali manj kot 0,5-krat tolikšna kot klinična izpostavljenost pri priporočenem kliničnem odmerku 2 g na dan pri bolnikih z ledvičnim presadkom in približno 0,3-krat tolikšna kot klinična izpostavljenost pri priporočenem kliničnem odmerku 3 g na dan pri bolnikih s srčnim presadkom (glejte poglavje 4.6).
English: There may be a transient increase in the free fraction and concentration of plasma MPA in patients with delayed renal graft function.
Slovenian: Pri bolnikih z zapoznelim delovanjem presadka se lahko pojavi prehodno povišanje proste frakcije in koncentracije mikofenolne kisline v plazmi.
English: This section will provide important background information concerning the teratogenicity and mutagenicity of mycophenolate mofetil.
Slovenian: ozadje teratogenosti in mutagenosti mofetilmikofenolata pri ljudeh To poglavje bo vsebovalo pomembne informacije o teratogenosti in mutagenosti mofetilmikofenolata.
English: Higher aciclovir plasma concentrations were observed when mycophenolate mofetil was administered with aciclovir in comparison to the administration of aciclovir alone.
Slovenian: Pri sočasni uporabi aciklovirja in mofetilmikofenolata so opazili zvečane koncentracije aciklovirja v plazmi v primerjavi s samostojnim jemanjem aciklovirja.
English: • Take 6 capsules in the morning and then 6 capsules in the evening.
Slovenian: • Vzemite 6 kapsul zjutraj in 6 kapsul zvečer.
English: • inflammation of the pancreas, colon or stomach
Slovenian: • vnetje trebušne slinavke, debelega črevesa ali želodca,
English: • If you are planning to become pregnant or if you get pregnant while taking Myclausen.
Slovenian: • če ste noseči, načrtujete nosečnost ali menite, da bi lahko bili noseči,
English: Capsule content Pregelatinised starch (maize) Croscarmellose sodium Povidone (K-30) Magnesium stearate
Slovenian: Jedro kapsul predgelirani škrob (koruzni) premrežen natrijev karmelozat povidon (K-30) magnezijev stearat
English: (body surface area - measured as square metres or ‘m2').
Slovenian: • Zdravnik bo določil najbolj ustrezen odmerek glede na višino in telesno maso otroka (telesna površina, izmerjena v kvadratnih metrih oziroma »m2«).
English: Therefore, a change in the dose of Myclausen should not normally be necessary in the absence of clinical evidence of graft dysfunction.
Slovenian: Zato v odsotnosti kliničnih znakov slabega delovanja presadka odmerka zdravila Myclausen ponavadi ni potrebno spreminjati.
English: A study of the co-administration of mycophenolate mofetil (1 g bid) and combined oral contraceptives containing ethinylestradiol (0.02 mg to 0.04 mg) and levonorgestrel (0.05 mg to 0.15 mg), desogestrel (0.15 mg) or gestodene (0.05 mg to 0.10 mg) conducted in 18 nontransplant women (not taking other immunosupressants) over 3 consecutive menstrual cycles showed no clinically relevant influence of mycophenolate mofetil on the ovulation suppressing action of the oral contraceptives.
Slovenian: V študiji je 18 žensk brez presadka (drugih imunosupresivov niso jemale) sočasno prejemalo 1 g mofetilmikofenolata dvakrat na dan in kombinirane kontraceptive, ki so vsebovali etinilestradiol (0,02 mg do 0,04 mg) in levonorgestrel (0,05 mg do 0,15 mg), desogestrel (0,15 mg) ali gestoden (0,05 mg do 0,10 mg).
English: Common Agitation, confusional state, depression,
Slovenian: Psihiatrične motnje zelo pogosti pogosti agitacija, stanje zmedenosti, depresija, anksioznost, nenormalno mišljenje, nespečnost
English: The systemic exposure at this dose represents 2-3 times the clinical exposure at the recommended clinical dose of 2 g/day in renal transplant patients and 1.3-2 times the clinical exposure at the recommended clinical dose of 3 g/day in cardiac transplant patients.
Slovenian: Sistemska izpostavljenost pri tem odmerku predstavlja 2- do 3-kratno klinično izpostavljenost pri priporočenem kliničnem odmerku 2 g na dan pri bolnikih z ledvičnim presadkom, in 1,3- do 2-kratno klinično izpostavljenost pri priporočenem kliničnem odmerku 3 g na dan pri bolnikih s srčnim presadkom.
English: Decrease in MPA Cmax and AUC (0-12h) by 30 % and 25 %, respectively, were observed when mycophenolate mofetil was concomitantly administered with sevelamer without any clinical consequences (i.e. graft rejection).
Slovenian: Pri sočasnem dajanju mofetilmikofenolata in sevelamerja so opazili zmanjšanje Cmax mikofenolne kisline za 30 % in AUC0-12 h mikofenolne kisline za 25 %, kliničnih posledic (zavrnitve presadka) pa ni bilo.
English: Women of childbearing potential
Slovenian: Bolnice v rodni dobi
English: By interfering with enterohepatic circulation of the medicinal product, bile acid sequestrants such as cholestyramine, reduce MPA AUC (see section 4.9).
Slovenian: Adsorbenti žolčnih kislin, kot je npr. holestiramin, vplivajo na enterohepatični obtok zdravila in s tem zmanjšajo AUC mikofenolne kisline (glejte poglavje 4.9).
English: In some of these cases switching mycophenolate mofetil to an alternative immunosuppressant resulted in serum IgG levels returning to normal.
Slovenian: V nekaj od teh primerov so se vrednosti serumskih IgG po zamenjavi zdravila Mofetilmikofenolata z drugim imunosupresivom vrnile na normalo.
English: Isolated cases of abnormal neutrophil morphology, including the acquired Pelger-Huet anomaly, have been observed in patients treated with mycophenolate mofetil.
Slovenian: Pri bolnikih, zdravljenih z mofetilmikofenolatom, so opazili posamezne primere nenormalne morfologije nevtrofilcev, vključno s pridobljeno Pelger-Huëtovo nepravilnostjo jedra granulocitov.
English: Mycophenolate causes birth defects and miscarriage.
Slovenian: Mikofenolat povzroča prirojene okvare in spontani splav.
English: Cholestyramine
Slovenian: Holestiramin
English: The recommended dose in renal transplant patients is 1 g administered twice daily (2 g daily dose).
Slovenian: Priporočeni odmerek pri bolnikih z ledvičnim presadkom je 1 g dvakrat na dan (dnevni odmerek 2 g).
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 500 mg mycophenolate mofetil. For the full list of excipients, see section 6.1.
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka filmsko obložena tableta vsebuje 500 mg mofetilmikofenolata.
English: NAME OF THE MEDICINAL PRODUCT Myclausen 250 mg hard capsules Mycophenolate mofetil
Slovenian: IME ZDRAVILA Myclausen 250 mg trdih kapsul mofetilmikofenolat
English: Myclausen 250 mg hard capsules Mycophenolate mofetil
Slovenian: Myclausen 250 mg trdih kapsul mofetilmikofenolat
English: Conversely, changes of MPA exposure should be expected when switching patients from CsA to one of the immunosuppressants which does not interfere with MPA´s enterohepatic cycle.
Slovenian: Nasprotno je pri prehodu z zdravljenja s ciklosporinom A na enega od imunosupresivov, ki ne vplivajo na enterohepatični obtok mikofenolne kisline, treba pričakovati spremembe izpostavljenosti mikofenolni kislini.
English: In healthy volunteers, no significant interaction was observed when mycophenolate mofetil was concomitantly administered with norfloxacin or metronidazole separately.
Slovenian: Pri dajanju mofetilmikofenolata skupaj z norfloksacinom ali metronidazolom zdravim prostovoljcem pomembnega medsebojnega delovanja niso opazili.
English: Tablet coat: Polyvinyl alcohol (partially hydrolysed), titanium dioxide (E 171) macrogol 3000,talc
Slovenian: Mikrokristalna celuloza, povidon (K-30), premrežen natrijev karmelozat, magnezijev stearat Obloga tablet: polivinilalkohol (delno hidroliziran), titanov dioksid (E 171), makrogol 3000, smukec
English: In contrast, there was an increase of approximately 20 % in tacrolimus AUC when multiple doses of mycophenolate mofetil (1.5 g BID) were administered to hepatic transplant patients taking tacrolimus.
Slovenian: Nasprotno, po dajanju večkratnih odmerkov mofetilmikofenolata (1,5 g dvakrat na dan) bolnikom z jetrnim presadkom, ki so jemali takrolimus, se je AUC takrolimusa povečala za približno 20 % .
English: MARKETING AUTHORISATION NUMBER(S) EU/1/10/647/001-002
Slovenian: ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/10/647/001-002
English: Liver transplant
Slovenian: Presaditev ledvic
English: The systemic exposure at this dose was approximately 0.5 times the clinical exposure at the recommended clinical dose of 2 g/day for renal transplant patients and approximately 0.3 times the clinical exposure at the recommended clinical dose of 3 g/day for cardiac transplant patients.
Slovenian: Sistemska izpostavljenost pri tem odmerku je bila približno 0,5 tolikšna večja kot klinična izpostavljenost pri priporočenem kliničnem odmerku 2 g na dan pri bolnikih z ledvičnim presadkom in približno 0,3-krat tolikšna kot klinična izpostavljenost pri priporočenem kliničnem odmerku 3 g na dan pri bolnikih s srčnim presadkom.
English: Capsule content: pre-gelatinised starch (maize), croscarmellose sodium, povidone (K-30), magnesium stearate
Slovenian: Jedro kapsul: predgelirani škrob (koruzni), premrežen natrijev karmelozatpovidon (K-30),magnezijev stearat.
English: • Swallow your tablets whole with a glass of water.
Slovenian: • Pogoltnite cele tablete z zadostno količino tekočine.
English: General unwanted effects
Slovenian: Glavni neželeni učinki
English: Cases of BK virus associated nephropathy, as well as cases of JC virus associated progressive multifocal leucoencephalopathy (PML), have been reported in patients treated with immunosuppressants, including mycophenolate mofetil. Agranulocytosis (≥ 1/1000 to < 1/100) and neutropenia have been reported; therefore, regular monitoring of patients taking Myclausen is advised (see section 4.4).
Slovenian: Poročali so tudi o agranulocitozi (≥ 1/1.000 do ≤ 1/100) in nevtropeniji, zato je priporočljivo bolnike, ki jemljejo zdravilo Myclausen, redno spremljati (glejte poglavje 4.4).
English: • The daily dose is 8 capsules (2 g of the medicine) taken as 2 separate doses.
Slovenian: • Dnevni odmerek so 8 kapsul (2 g zdravila), ki se jemlje v 2 posameznih odmerkih.
English: The pharmacokinetics and pharmacodynamics of oral contraceptives were unaffected by coadministration of mycophenolate mofetil (see also section 5.2).
Slovenian: Sočasno jemanje mofetilmikofenolata ni vplivalo na farmakokinetiko in farmakodinamiko peroralnih kontraceptivov (glejte tudi poglavje 5.2).
English: The available evidence does not indicate an increased risk of malformations or miscarriage if the father takes mycophenolate.
Slovenian: Kontracepcija pri moških, ki jemljejo zdravilo Myclausen Razpoložljivi podatki ne kažejo na povečano tveganje za okvare ali splav, če mofetilmikofenolat uporablja oče.
English: However, hepatic disease with predominantly biliary damage, such as primary biliary cirrhosis, may show a different effect.
Slovenian: Drugačen učinek pa se lahko pokaže pri nekaterih drugih jetrnih boleznih, pri katerih gre predvsem za poškodbe žolčnih izvodil, kot je npr. primarna biliarna ciroza.
English: In experimental models, mycophenolate mofetil was not tumourigenic.
Slovenian: Mofetilmikofenolat v eksperimentalnih modelih ni bil kancerogen.
English: Common Hepatitis, jaundice, hyperbilirubinaemia
Slovenian: Bolezni jeter, žolčnika in žolčevodov zelo pogosti pogosti hepatitis, zlatenica, hiperbilirubinemija